New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.
Credit: Source link
Friday, July 17, 2026
New non-opioid painkiller approved by US health agency
BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!
